RespirTech
RespirTech is a Plymouth, Minnesota-based medical device company (wholly owned by Philips since 2017) that develops and distributes prescription-based high-frequency chest wall oscillation vest therapy for patients with bronchiectasis, cystic fibrosis, COPD, and neuromuscular respiratory conditions, supported by in-home training, insurance navigation, and the world's largest bronchiectasis outcomes registry.
- Company typePrivate
- Founded2004
- HeadquartersMinneapolis, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What RespirTech does
RespirTech (legal entity: Respiratory Technologies, Inc.) is a Plymouth, Minnesota-based medical device company founded in 2004 and wholly owned by Koninklijke Philips N.V. since 2017. The company develops and distributes airway clearance therapy hardware — principally the Philips InCourage System, a high-frequency chest wall oscillation (HFCWO) vest device that uses a proprietary triangle waveform (covered by US Patent 6,958,046) to mobilize and clear excess lung secretions. Its portfolio also included the Philips Respironics CoughAssist T70 mechanical insufflation-exsufflation device until that line was discontinued in September 2023, with service and parts support continuing through October 1, 2028.
RespirTech sells through a prescription-based, payer-reimbursed distribution model: physicians prescribe its devices, the company coordinates insurance coverage with Medicare, Medicaid, the Veterans Health Administration, and commercial plans, and licensed respiratory therapists and registered nurses deliver devices to patients' homes and train them on use. The company maintains the world's largest bronchiectasis patient registry, with longitudinal outcomes data collected from over 25,000 patients since 2013, and runs dedicated outcomes programs for the general patient population and the VA.
The company serves four primary patient segments — adults with bronchiectasis (often comorbid with COPD), cystic fibrosis patients, patients with neuromuscular or neuromotor disorders such as ALS, muscular dystrophy, and cerebral palsy, and veterans with chronic respiratory disease — through referrals from pulmonologists, clinical educators, and patient advocacy outreach. Headcount is reported at 51-100 employees, and the business is wholly consolidated into Philips' Respiratory Care franchise.
RespirTech firmographics
Firmographics- Name
- RespirTech
- Legal name
- Respiratory Technologies, Inc.
- Website
- https://respirtech.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- RespirTech is a Plymouth, Minnesota-based medical device company (wholly owned by Philips since 2017) that develops and distributes prescription-based high-frequency chest wall oscillation vest therapy for patients with bronchiectasis, cystic fibrosis, COPD, and neuromuscular respiratory conditions, supported by in-home training, insurance navigation, and the world's largest bronchiectasis outcomes registry.
- Ownership category
- akta.pro rank
RespirTech industry classification
Industry- Product category
- Respiratory Medical Devices
- akta.pro primary industry
- Chest Physiotherapy & Airway Clearance Devices (PEP, Oscillatory PEP, HFCWO, Cough Assist) (HLAHAGAJ)
- akta.pro secondary industries
- Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Home Respiratory & Ventilator Care (Skilled) (HLADAFAI), Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)
Keywords
Where RespirTech is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RespirTech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Medical Device Sales (HFCWO Vest Systems): Sale of Philips InCourage vest therapy systems and Philips Respironics CoughAssist T70 devices. Requires physician prescription and is typically covered by health insurance including Medicare, Medicaid, and commercial plans.
- Equipment Rental and Supplies: Replacement accessories, repair parts, and supplies for existing devices. CoughAssist service and support continued through October 1, 2028 following September 2023 discontinuation.
- Insurance Reimbursement: Revenue through insurance reimbursement from Medicare, Medicaid, Veterans Health Administration (VA), and commercial health insurance plans.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Insurance-covered medical equipment |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
RespirTech product offering
Product offeringCore offering
RespirTech provides airway clearance therapy solutions, primarily the Philips InCourage HFCWO (high-frequency chest wall oscillation) vest therapy system, to patients with chronic respiratory conditions including bronchiectasis, cystic fibrosis, COPD, and neuromuscular disease. The company manages the full prescription-to-home-delivery workflow and wraps the device with a patient support program that includes in-home respiratory therapist setup, insurance coverage verification, and ongoing clinical follow-up. Its proprietary Triangle Waveform (US Patent 6958046) and Active Venting design differentiate the InCourage system from competing HFCWO vests on the market.
Product overview
RespirTech, a Philips company, offers a focused portfolio of airway clearance products and support services for patients with chronic respiratory conditions. The core product line includes the Philips InCourage System (high-frequency chest wall oscillation vest therapy using proprietary triangle waveform technology) and the now-discontinued Philips Respironics CoughAssist T70 (mechanical insufflation-exsufflation device). These devices are complemented by RespirTech's comprehensive patient support program, which provides insurance navigation, in-home training, and ongoing monitoring through the world's largest bronchiectasis patient registry. The company serves patients with bronchiectasis, COPD, cystic fibrosis, and neuromuscular disorders affecting respiratory function.
Differentiator
Problem solved
Functional benefit
Products and services
- Philips InCourage System High-frequency chest wall oscillation (HFCWO) vest therapy system that uses a proprietary Triangle Waveform (US Patent 6958046) and Active Venting technology to deliver air pulses that thin and mobilize airway secretions for patients with chronic respiratory conditions such as bronchiectasis, cystic fibrosis, COPD, and neuromuscular disease. Prescribed by clinicians, delivered to the home, and reimbursed through Medicare, Medicaid, Veterans Health Administration, and commercial payors.
- Philips Respironics CoughAssist T70 Mechanical insufflation-exsufflation device providing non-invasive airway clearance for patients with reduced ability to cough, particularly those with neuromuscular disease. Originally sold through RespirTech's prescription channel; new sales discontinued September 12, 2023, with RespirTech continuing service and support for existing patients through October 1, 2028.
- InCourage Comfort Vest Replacement vest accessory for the Philips InCourage HFCWO system, available in multiple sizes and used during therapy sessions to deliver chest wall oscillation comfortably across patient body types.
- RespirTech Patient Support Program Comprehensive patient support service for individuals prescribed airway clearance therapy, including in-home device setup and training by respiratory therapists, insurance coverage verification and prior authorization assistance, ongoing adherence and clinical follow-up, and dedicated patient advocates. Designed to improve real-world adherence and outcomes for patients on daily HFCWO therapy.
Quantifiable outcome
- Yearly rate of hospitalization decreased by 62% after 12 months of InCourage vest therapy
- +9 more outcomes
Companies that use RespirTech
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles2 records
RespirTech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
RespirTech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Royal Philips N.V.coreRespirTech was acquired by Philips in 2017. As a Philips company, RespirTech helps people with chronic respiratory conditions through Philips InCourage vest therapy and Philips Respironics products. The acquisition strengthened the goal of improving quality of life for patients with respiratory complications.
Scale indicators9 records
Recent moves5 records
Expansion highlights5 records
RespirTech competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Diversified medical device major with respiratory and patient monitoring solutions that intersect with RespirTech's outcomes-tracking and chronic care patient base.
- Drägerwerk: Large medical technology company with a strong portfolio in ventilation and airway management. Operates broadly in hospital and home respiratory care where RespirTech's neuromuscular and COPD patients are also served.
- Koninklijke Philips N.V. Parent company of RespirTech and the largest competing respiratory franchise globally (Respironics CPAP/BiPAP, hospital ventilation). While Philips owns RespirTech, adjacent internal product lines overlap in patient populations and prescribers, making it both parent and partial competitor.
- Fisher & Paykel Healthcare: Global leader in respiratory humidification, CPAP, and nasal high-flow therapy. Competes for the chronic respiratory patient wallet and prescriber relationships, particularly in COPD and neuromuscular overlap segments.
- Teleflex: Manufacturer of airway management devices (endotracheal tubes, laryngeal masks, suction). Adjacent in the airway clearance care pathway and shares hospital and home respiratory prescribers with RespirTech.
Direct peers
- Vyaire Medical: Respiratory care device manufacturer offering airway clearance and ventilation products, including competing solutions in hospital and home respiratory care. Comparable in airway clearance focus and payor-dependent revenue model.
- Baxter International (Hill-Rom Respiratory Care): Through the Hill-Rom acquisition, Baxter offers The Vest airway clearance system — a long-standing HFCWO competitor. Overlapping patient populations and reimbursement infrastructure make this the most direct competing device franchise.
- Electromed: Direct competitor in HFCWO vest therapy with the SmartVest system targeting bronchiectasis, CF, COPD, and neuromuscular patients. Closest pure-play comparable to RespirTech's InCourage system in indications, channel, and payor mix.
Emerging players
- International Biophysics: Smaller HFCWO competitor with a focus on affordability and emerging markets. Represents the lower-cost disruptive end of the same vest therapy category RespirTech competes in.
- Monaghan Medical: Specialises in oscillatory PEP devices (Acapella) and positive expiratory pressure airway clearance — a non-vest but directly competing airway clearance modality for bronchiectasis, CF, and COPD patients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
RespirTech social profiles
Digital presenceRespirTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
RespirTech leadership team
Management profileNumber of profiles
Profiles7 records
RespirTech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RespirTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RespirTech
What does RespirTech do?
RespirTech provides airway clearance therapy solutions, primarily the Philips InCourage HFCWO (high-frequency chest wall oscillation) vest therapy system, to patients with chronic respiratory conditions including bronchiectasis, cystic fibrosis, COPD, and neuromuscular disease. The company manages the full prescription-to-home-delivery workflow and wraps the device with a patient support program that includes in-home respiratory therapist setup, insurance coverage verification, and ongoing clinical follow-up. Its proprietary Triangle Waveform (US Patent 6958046) and Active Venting design differentiate the InCourage system from competing HFCWO vests on the market.
Is RespirTech a public or private company?
RespirTech is a private company. It is classified as corporate owned and is currently operating.
When was RespirTech founded?
RespirTech was founded in 2004. It employs 51 to 100 people.
Where is RespirTech based?
RespirTech is headquartered in Minneapolis, United States, in the North America region.
How does RespirTech make money?
Three revenue lines are on record. Medical Device Sales (HFCWO Vest Systems) is the primary driver. The others are equipment Rental and Supplies and insurance Reimbursement.
Who are RespirTech's main competitors?
Broad incumbents on record are Medtronic, Drägerwerk, Koninklijke Philips N.V., Fisher & Paykel Healthcare and Teleflex. Direct peers are Vyaire Medical, Baxter International (Hill-Rom Respiratory Care) and Electromed. Emerging players are International Biophysics and Monaghan Medical.
Does RespirTech have an API?
No public API is recorded for RespirTech.
What industry is RespirTech in?
RespirTech's product category is Respiratory Medical Devices. Its primary akta.pro industry code is HLAHAGAJ, Chest Physiotherapy & Airway Clearance Devices (PEP, Oscillatory PEP, HFCWO, Cough Assist), with a secondary code of HSABAKAD, Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers).